Biostatisticians H-1B salary at AstraZeneca Pharmaceuticals LP: $153,950 average ($114,400-$210,698 range). 100% approval rate.
With 30 H-1B filings, AstraZeneca Pharmaceuticals LP is an active sponsor of Biostatisticians positions at an average salary of $154k. The average offered salary of $154k is 70% above the prevailing wage for this occupation. Most positions are located in Massachusetts (37%), Maryland (27%), Delaware (20%). The certification rate is 100%. 37% of these filings are for new employment.
| Total Filings | 30 |
| Approval Rate | 100% |
| Average Salary | $153,950 |
| Median Salary | $144,707 |
| 25th Percentile | $130,515 |
| 75th Percentile | $173,640 |
| Minimum Salary | $114,400 |
| Maximum Salary | $210,698 |
| Percentile | Salary |
|---|---|
| 10th | $122k |
| 25th | $131k |
| 50th (Median) | $145k |
| 75th | $174k |
| 90th | $205k |
Based on 30 salary records. Range: $114k – $211k.
100% of filings offer salaries above the prevailing wage, with an average premium of 75.4%. The average prevailing wage is $90k (based on 30 filings with prevailing wage data).
Average processing time is 7 days (median: 7 days). Fastest: 7 days, slowest: 10 days. Based on 30 filings.
37% of filings are for new positions, while 27% are for continued employment (30 filings with data).
Average contract duration: 36 months (median: 36 months), based on 30 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 30 |
| State | Filings |
|---|---|
| Massachusetts | 11 |
| Maryland | 8 |
| Delaware | 6 |
| California | 3 |
| New Jersey | 1 |
| Connecticut | 1 |
AstraZeneca Pharmaceuticals LP has 30 H-1B filings for Biostatisticians positions in our database of DOL public records.
The average H-1B salary for Biostatisticians at AstraZeneca Pharmaceuticals LP is $153,950, with a median of $144,707. Salaries range from $114,400 to $210,698.
The H-1B approval rate for Biostatisticians positions at AstraZeneca Pharmaceuticals LP is 100% based on 30 DOL filings.
See how Biostatisticians salaries compare across different H-1B sponsors.